Get started
Author

Marjolein J.A.L. Wetzels

Observed names: M. Wetzels, Marjolein J A L Wetzels, Marjolein Wetzels
ORCID: 0000-0003-2501-3230
Observed ORCID: 0000-0003-2501-3230
OpenAlex ID: A5007189396
Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response
2020 · Monique K. van der Kooij, Marjolein J.A.L. Wetzels, et al. · Cancers · 43
PDF
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report
2025 · Mieke van Schaik, Eline J Arends, et al. · Lupus Science & Medicine · 15
PDF
Topoisomerase 1-DNA complexes are preferentially recognised by a subset of anti-topoisomerase 1 autoantibodies and their corresponding B cell receptors in systemic sclerosis
2026 · Sam Neppelenbroek, Corrie M. Wortel, et al. · Annals of the Rheumatic Diseases · 1
PDF
Enhanced recognition of topoisomerase 1 upon DNA binding by a subset of anti-topoisomerase 1 autoantibodies in systemic sclerosis
2025 · Sam Neppelenbroek, Corrie M. Wortel, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
#2772 Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report
2025 · Mieke van Schaik, Eline Arends, et al. · Nephrology Dialysis Transplantation
PDF
Abs0517 Long-term Safety and Efficacy of the Combination of Belimumab and Rituximab in the Treatment of Severe and Refractory Sle: a Preliminary Report
2025 · M. van Schaik, E. Arends, et al. · Annals of the Rheumatic Diseases
Works count: 6
Citation count: 60
H-index: 2
I10-index: 2
Year
Topic
Type